Pernod Ricard Shares Show Muted Response to Chinese Tariff Relief

A significant overhang that pressured Pernod Ricard for months has finally lifted, yet investor enthusiasm remains notably subdued. In a surprising turn of events, China’s Ministry of Commerce imposed anti-dumping duties on EU brandy imports this Friday but granted a crucial exemption for major producers, including Pernod Ricard. This development should have provided a substantial boost to the French spirits giant, which has endured a severe 21% sales decline in China during fiscal 2025. The muted market reaction, however, suggests a more complex narrative may be at play.

Exemption from Tariffs Removes Major Obstacle

The timing of Beijing’s decision offers considerable relief. Pernod Ricard’s performance in China had been hampered by weak consumer demand and the persistent threat of new import duties, which collectively drove the recent double-digit revenue contraction. The newly announced sanctions, which reach as high as 34.9%, specifically target EU brandy producers. However, a critical exemption clause for premium brands meeting a certain minimum price point means Pernod Ricard, along with LVMH and Remy Cointreau, will not be affected. This effectively neutralizes an existential threat to a market that generates $3 billion in annual exports.

Investor Sentiment Remains Cautious

Despite this positive resolution, the equity response was unexpectedly tepid. Pernod Ricard shares closed Friday’s session down 1.04% at €95.54. This lukewarm reception can likely be attributed to two factors: the market may have already priced in a favorable outcome, or broader macroeconomic concerns are outweighing the company-specific news. Concurrently with the brandy decision, China also announced tariffs on EU pork imports, signaling that broader trade tensions between the bloc and Beijing are far from resolved.

Should investors sell immediately? Or is it worth buying Pernod Ricard.?

Persistent Headwinds in Key Markets

Beyond China, Pernod Ricard continues to navigate a challenging global landscape. The United States market has also shown signs of softening, contributing to an overall organic sales decline of 3% for FY2025, with revenue settling at €10.96 billion. Further complicating the outlook are regulatory obstacles in critical growth markets like India, where the company recently received a third license rejection for its operations in Delhi. Despite these hurdles, management has expressed confidence, framing fiscal 2026 as a transitional year with a projected recovery anticipated in the second half.

The Path Forward for Recovery

The removal of the Chinese tariff threat clears a significant barrier for Pernod Ricard to achieve its long-term ambition of 3-6% annual organic sales growth through 2029. The company’s next major test arrives on February 19, 2026, when its half-year results will provide the first concrete evidence of whether a genuine rebound in China is underway. Until then, investors will be watching closely to see if the market eventually recognizes the full strategic importance of this regulatory reprieve.